XML 80 R61.htm IDEA: XBRL DOCUMENT v3.22.4
SHAREHOLDERS EQUITY (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Feb. 11, 2021
Nov. 30, 2022
Jan. 31, 2022
Sep. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Common stock share sold       2,869,442    
Issued warrants in concurrent private placement       1,434,721    
Issued warrants in concurrent placement agent       172,167    
Terms of outstanding warrants to purchase   $ 593,750   $ 2.18    
Proceeds from issuance of warrants       $ 4,581,651 $ 0 $ 4,581,651
Exercise price of warrant       $ 1.68    
Warrant amendment, description In connection with the Warrant Amendment, TOMI repurchased the warrant from Dr. Shane (the “Repurchase”) for an aggregate cash consideration of $314,500, representing a 15% discount of the net exercise cash value of the Warrant, which was calculated using the closing price of the Common Stock on the Nasdaq on February 11, 2021 of $5.36, less the exercise price of the warrants in the amount of $2.40. On the same date, the Warrant Amendment and the Repurchase was considered, approved and adopted by a disinterested majority of TOMI’s board of directors.          
Aggregate cash consideration $ 314,500          
Warrants issued upon purchase share of common stock 125,000          
Common stock value         197,640 $ 196,810
Expected dividend yield   0.00%        
Risk free interest rate   4.31%        
Contractual term   10 years        
Share based compensation expense         $ 356,000  
Minimum [Member]            
Grant fair value of per share   $ 0.17        
Volatility rate   83.00%        
Expected life term   1 month 13 days        
Maximum [Member]            
Grant fair value of per share   $ 0.65        
Volatility rate   163.00%        
Expected life term   11 years 2 months 23 days        
Cumulative Convertible Series A Preferred Stock            
Preferred stock shares         1,000,000 1,000,000
Cumulative Convertible Preferred Stock; Shares Issued         63,750 63,750
Cumulative Convertible Preferred Stock; Shares Outstanding         63,750 63,750
Cumulative Convertible Preferred Stock; Par Value         $ 0.01 $ 0.01
Cumulative Convertible Series B Preferred Stock            
Preferred stock shares         4,000 4,000
Cumulative Convertible Preferred Stock; Shares Issued         0 0
Cumulative Convertible Preferred Stock; Shares Outstanding         0 0
January 2022 [Member]            
Common stock share issued         51,750  
Common stock value         $ 228,000  
January 2021 [Member]            
Common stock value           $ 228,000
Private Placement [Members]            
Exercise price of warrant       1.68    
Placement Agent [Members]            
Exercise price of warrant       $ 2.18    
Warrant issued       $ 172,167    
CEO [Member] | Stock Options            
Grant fair value of per share     $ 1.03      
Volatility rate     156.00%      
Expected dividend yield     0.00%      
Risk free interest rate     1.65%      
Aggregate shares purchase of stock option     172,500      
Fair value of stock option     $ 178,281      
Contractual term     10 years      
Expected life term     5 years      
Exercise price     $ 1.12      
CEO [Member] | January Twenty Two [Member] | Stock Option [Member]            
Grant fair value of per share     $ 1.03      
Warrants issued upon purchase share of common stock     40,000      
Volatility rate     156.00%      
Expected dividend yield     0.00%      
Risk free interest rate     1.65%      
Fair value of stock option     $ 41,340      
Contractual term     10 years      
Expected life term     5 years      
Exercise price     $ 1.12